Elena Ostrovsky

Elena Ostrovsky is a prominent inventor based in Rishon Le-Zion, Israel. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of insulin formulations and methods for their use in preterm infants. With a total of 4 patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

One of her latest patents focuses on insulin formulations and methods of using them in preterm infants. This innovative insulin preparation includes insulin, oligosaccharide, and sodium chloride at a specific ratio of 1:A:B (w:w:w), with A and B ranging from 1000-5000 and 10-50, respectively. Another notable patent is the (1R, 1'R)-atracurium salts separation process, which provides an improved method for chromatographically separating the isomers of (1R,rR)-atracurium salts using high-performance liquid chromatography (HPLC) without the need for a strong acid. This separation is preferably conducted on a silica gel HPLC column with an eluent that contains an organic solvent, a polar aprotic co-solvent, and a weak organic acid.

Career Highlights

Elena has worked with several companies, including Chemagis Ltd. and Elgan Pharma Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Elena has collaborated with notable coworkers such as Oded Arad and Michal Olshansky. These partnerships have further enhanced her innovative capabilities and expanded her impact in the pharmaceutical industry.

Conclusion

Elena Ostrovsky is a remarkable inventor whose work in pharmaceutical formulations is paving the way for advancements in medical treatments. Her contributions, particularly in insulin formulations for preterm infants, highlight her dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.